436 related articles for article (PubMed ID: 27668551)
1. Association of the brain-derived neurotrophic factor Val66Met polymorphism with negative symptoms severity, but not cognitive function, in first-episode schizophrenia spectrum disorders.
Mezquida G; Penadés R; Cabrera B; Savulich G; Lobo A; González-Pinto A; Penzol MJ; Corripio I; Fernandez-Egea E; Gassó P; Cuesta MJ; Bernardo M;
Eur Psychiatry; 2016 Oct; 38():61-69. PubMed ID: 27668551
[TBL] [Abstract][Full Text] [Related]
2. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
[TBL] [Abstract][Full Text] [Related]
3. [Association study of brain-derived neurotrophic factor Val66Met polymorphism and clinical characteristics of first episode schizophrenia].
Sun MM; Liu LF; Yang LM; Wang Y; Cui KY; Wang LN; Li CL; Qiao DD; Wang RZ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Apr; 29(2):155-8. PubMed ID: 22487823
[TBL] [Abstract][Full Text] [Related]
4. BDNF gene polymorphism, cognition and symptom severity in a Brazilian population-based sample of first-episode psychosis subjects.
Martinho E; Michelon L; Ayres AM; Scazufca M; Menezes PR; Schaufelberger MS; Murray RM; Rushe TM; Vallada H; Busatto Filho G
Braz J Psychiatry; 2012 Oct; 34 Suppl 2():S219-25. PubMed ID: 23429848
[TBL] [Abstract][Full Text] [Related]
5. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease.
Pivac N; Nikolac M; Nedic G; Mustapic M; Borovecki F; Hajnsek S; Presecki P; Pavlovic M; Mimica N; Muck Seler D
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):356-62. PubMed ID: 21044653
[TBL] [Abstract][Full Text] [Related]
6. A role for the BDNF gene Val66Met polymorphism in schizophrenia? A comprehensive review.
Notaras M; Hill R; van den Buuse M
Neurosci Biobehav Rev; 2015 Apr; 51():15-30. PubMed ID: 25562189
[TBL] [Abstract][Full Text] [Related]
7. Brain-derived neurotrophic factor Val66Met polymorphism and obsessive-compulsive symptoms in Egyptian schizophrenia patients.
Hashim HM; Fawzy N; Fawzi MM; Karam RA
J Psychiatr Res; 2012 Jun; 46(6):762-6. PubMed ID: 22521161
[TBL] [Abstract][Full Text] [Related]
8. Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls.
Zhang XY; Chen DC; Xiu MH; Haile CN; Luo X; Xu K; Zhang HP; Zuo L; Zhang Z; Zhang X; Kosten TA; Kosten TR
Hum Genet; 2012 Jul; 131(7):1187-95. PubMed ID: 22362486
[TBL] [Abstract][Full Text] [Related]
9. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.
Rybakowski JK; Borkowska A; Skibinska M; Szczepankiewicz A; Kapelski P; Leszczynska-Rodziewicz A; Czerski PM; Hauser J
Psychiatry Clin Neurosci; 2006 Feb; 60(1):70-6. PubMed ID: 16472361
[TBL] [Abstract][Full Text] [Related]
10. [Association of Val66Met polymorphism of brain-derived neurotrophic factor gene with cognitive impairment and clinical symptoms in first episode schizophrenia].
Zhang C; Gu X; Wang Q; Li M; Deng W; Guo W; Zhao L; Ma X; Li T
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Aug; 34(4):592-596. PubMed ID: 28777866
[TBL] [Abstract][Full Text] [Related]
11. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.
Numata S; Ueno S; Iga J; Yamauchi K; Hongwei S; Ohta K; Kinouchi S; Shibuya-Tayoshi S; Tayoshi S; Aono M; Kameoka N; Sumitani S; Tomotake M; Kaneda Y; Taniguchi T; Ishimoto Y; Ohmori T
Neurosci Lett; 2006 Jun; 401(1-2):1-5. PubMed ID: 16533563
[TBL] [Abstract][Full Text] [Related]
12. The BDNF Val66Met polymorphism and plasma brain-derived neurotrophic factor levels in Han Chinese patients with bipolar disorder and schizophrenia.
Chen SL; Lee SY; Chang YH; Chen SH; Chu CH; Wang TY; Chen PS; Lee IH; Yang YK; Hong JS; Lu RB
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():99-104. PubMed ID: 24468644
[TBL] [Abstract][Full Text] [Related]
13. Association among aggressiveness, neurocognitive function, and the Val66Met polymorphism of brain-derived neurotrophic factor gene in male schizophrenic patients.
Chung S; Chung HY; Jung J; Chang JK; Hong JP
Compr Psychiatry; 2010; 51(4):367-72. PubMed ID: 20579509
[TBL] [Abstract][Full Text] [Related]
14. Val66Met functional polymorphism and serum protein level of brain-derived neurotrophic factor (BDNF) in acute episode of schizophrenia and depression.
Skibinska M; Groszewska A; Kapelski P; Rajewska-Rager A; Pawlak J; Dmitrzak-Weglarz M; Szczepankiewicz A; Twarowska-Hauser J
Pharmacol Rep; 2018 Feb; 70(1):55-59. PubMed ID: 29331787
[TBL] [Abstract][Full Text] [Related]
15. Hippocampal volume and the brain-derived neurotrophic factor Val66Met polymorphism in first episode psychosis.
Smith GN; Thornton AE; Lang DJ; Macewan GW; Ehmann TS; Kopala LC; Tee K; Shiau G; Voineskos AN; Kennedy JL; Honer WG
Schizophr Res; 2012 Feb; 134(2-3):253-9. PubMed ID: 22192502
[TBL] [Abstract][Full Text] [Related]
16. The impact of BDNF Val66Met polymorphism on cognition in Bipolar Disorder: A review: Special Section on "Translational and Neuroscience Studies in Affective Disorders" Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders.
Mandolini GM; Lazzaretti M; Pigoni A; Delvecchio G; Soares JC; Brambilla P
J Affect Disord; 2019 Jan; 243():552-558. PubMed ID: 30078664
[TBL] [Abstract][Full Text] [Related]
17. BDNF Val66Met polymorphism and anxiety/depression symptoms in schizophrenia in a Chinese Han population.
Sun MM; Yang LM; Wang Y; Feng X; Cui KY; Liu LF; Chen ZY
Psychiatr Genet; 2013 Jun; 23(3):124-9. PubMed ID: 23532065
[TBL] [Abstract][Full Text] [Related]
18. Association between BDNF Val66Met polymorphism and cognitive performance in antipsychotic-naïve patients with schizophrenia.
Lu W; Zhang C; Yi Z; Li Z; Wu Z; Fang Y
J Mol Neurosci; 2012 Jul; 47(3):505-10. PubMed ID: 22477643
[TBL] [Abstract][Full Text] [Related]
19. Brain-derived neurotrophic factor (BDNF) and neurocognitive deficits in people with schizophrenia: a meta-analysis.
Ahmed AO; Mantini AM; Fridberg DJ; Buckley PF
Psychiatry Res; 2015 Mar; 226(1):1-13. PubMed ID: 25681004
[TBL] [Abstract][Full Text] [Related]
20. Smoking and BDNF Val66Met polymorphism in male schizophrenia: a case-control study.
Zhang XY; Chen DC; Tan YL; Luo X; Zuo L; Lv MH; Shah NN; Zunta-Soares GB; Soares JC
J Psychiatr Res; 2015 Jan; 60():49-55. PubMed ID: 25455509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
